Skip to content

The Effect of Lateral Tilt on Ventilation Distribution in Lungs Assessed by Electrical Impedance Tomography

The Effect of Lateral Tilt on Ventilation Distribution in Lungs Assessed by Electrical Impedance Tomography: A Pilot Prospective Randomized Study in Neurocritical Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04235231
Acronym
N-LAT-EIT
Enrollment
250
Registered
2020-01-21
Start date
2021-06-01
Completion date
2024-10-09
Last updated
2025-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Collapse

Keywords

Lung Inhomogeneity, Lung Collapse, Atelectasis, Mechanical Ventilation, EIT, Bed tilting, Positioning, Neurocritical Care, Unconsciousness, Acute Brain Disease, Preventive Strategy

Brief summary

Prevention of lung inhomogeneity is an essential part of preventive strategy in neurocritical care, reducing the risks of secondary brain damage from hypoxemia, hypo/hypercapnia or pneumonia.

Detailed description

In the monocentric, intervention, prospective, randomized study, the investigators will examine the effect of lateral tilting (routinely used in critical care) on the lung inhomogeneity that will be analyzed by electrical impedance tomography (EIT) in the unconscious patients with acute primary brain disease and artificial pulmonary ventilation. Two types of lateral tilting will be compared: manual positioning of body by nurse versus the bed tilting (15° lateral tilt, original company (LINET) and product brand name (Eleganza 5).

Interventions

DEVICEBed tilting

15° lateral tilt, original product brand name LINET Eleganza 5

Manual positioning of body by nurse: left side, back, right side, using positioning pillows

Sponsors

Charles University, Czech Republic
CollaboratorOTHER
University of Sao Paulo
CollaboratorOTHER
Technology Agency of the Czech Republic
CollaboratorUNKNOWN
Regional Hospital Liberec
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Masking description

Research Randomizer

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Primary brain disease * Hospitalization in Neurocenter, Neurointensive Care Unit * Age\>18 years * Unconsciousness * Artificial pulmonary ventilation

Exclusion criteria

* Intracranial hypertension * History of primary lung disease * The terminal stage of the disease * Refractory hemodynamic instability

Design outcomes

Primary

MeasureTime frameDescription
Atelectasis/collapseup to 24 weeksAssessed by electrical impedance tomography (EIT) or chest x-ray (CXR) at end of observation period

Secondary

MeasureTime frameDescription
Evaluating oxygenation parametersup to 24 weeksOxygen saturation
Evaluating hemodynamic parametersup to 24 weeksHemodynamic monitoring: stroke volume variation (SVV)
Cost effectiveness measurement between two groupsup to 24 weeksTherapeutic Intervention Scoring System (TISS)
Profiling pneumonia incidenceup to 24 weeksPneumonia score
Comparing duration of stay in Neurocenter Neurointensive Care Unitup to 24 weeksDays of hospitalization

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026